I agree that there is still hope but....that hope, however, rests on the efficacy of the peptides that Generex is evaluating. I believed, incorrectly as it turns out, that the peptide evaluation process had begun in early June and would conclude in a month or two. The PR about the July 10 CC implied that the peptide evaluation had not yet begun. As sincere as joe may be, I don’t anticipate that Generex will get a cent from either BARDA or CEPI until they can demonstrate that one or more of the peptides actually work. Heaven only knows when that might occur. But there is hope.